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TITLE OF CASE 
SUCCESS OF A SUSTAINED PHARMACEUTICAL CARE SERVICE WITH ELECTRONIC 
ADHERENCE MONITORING IN A DIABETIC PATIENT OVER 12 MONTHS 
 
SUMMARY 
We report of the first polypharmacy adherence monitoring over 371 days, integrated in a 
pharmaceutical care service (counselling, electronic multidrug punch cards, feedback on 
recent electronic records) for a 65-year old male diabetic patient after hospital discharge. 
The initial 4-times daily regimen with 15 daily pills changed after 79 days into a 2-times 
daily regimen with 9 daily pills for the next 292 days. The patient removed all medication 
from the multidrug punch cards (taking adherence 100%) and had 96.9% correct dosing 
intervals (timing adherence). The 57 evening doses showed the least variation in intake 
times at 17h 45min ± 8min. Over the observation year, the patient was clinically stable. The 
patient was very satisfied with the multidrug punch card use and the feedbacks on electronic 
records. In conclusion, long-term monitoring of polypharmacy was associated with the 
benefit of successful disease management. 
 
BACKGROUND  
According to its latest definition, "Pharmaceutical Care is the pharmacist's contribution to the 
care of individuals in order to optimize medicines use and improve health outcomes".[1] 
Thus, medication adherence, i.e., the extent of a patient following the recommendations by 
a health-care professional, represents a central concern in pharmacy practice. With typical 
adherence rates for oral prescription medication of approximately 50-76% ,[2, 3] non-
adherence has been designated as one of the largest health care problems in society ,[3-5] 
since it impairs clinical outcomes and quality of life, and generates costs.[6-10] 
Polypharmacy, i.e. the use of multiple drugs administered to the same patient ,[11] has 
been described as a factor strongly related to non-adherence.[12, 13] However, 
polypharmacy has become common because of e.g. clinical practice relying on multidrug 
combinations, increased rates of comorbidities and the aging population. In this context, 
dose-dispensing aids such as multidrug punch cards are suggested to improve adherence to 
polypharmacy and clinical outcomes.[14-16]  
Electronic monitoring is considered nearest to gold standard in adherence measurement.[17] 
Several studies used a pill bottle with a computer chip equipped cap that records each 
opening of the bottle. Because of the design of this pill bottle, one lead drug can be 
monitored at one time.[18-22] The recent development of printed electric circuitries and 
RFID technology made it possible to monitor polypharmacy by using a paper foil and a chip 
collecting real time data (Confrérie Clinique S.A., Lausanne, Switzerland) affixed on the back 
of a multidrug punch card.[23] The POlypharmacy Electronic Monitoring System (POEMS) 
records date, time, and location of medication removal of the whole therapy regimen.  
 
We report of the first polypharmacy adherence monitoring over 12 months, integrated in a 
pharmaceutical care service for a diabetic patient after hospital discharge. The patient was 
recruited within a pilot study to prove feasibility of a pharmaceutical care service with 
electronic adherence monitoring (ClinTrials.gov Identifier: NCT01759095). 
 
CASE PRESENTATION  
We report of a 65-year old male patient who was hospitalized for a sepsis by Staphylococcus 
aureus at a large Swiss university hospital from January 28th to February 18th 2013. His 
actual diagnoses included late onset autoimmune diabetes in the adult (HbA1C: 8%, 
30.01.2013) with manifest complications (diabetic foot with chronic osteomyelitis, non-
proliferative retinopathy, polyneuropathy), coronary heart disease with double stenting 
during the actual hospitalisation (LDL: 2.83 mmol/l, 01.02.2013; TG: 1.82 mmol/l, 
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01.02.2013), and a beginning heart failure (LVEF 40%, blood pressure: 183/93 mmHg, 
18.02.2013). Signs of a beginning dementia were reported but not further investigated. He 
was retired, lived independently and alone in a middle-sized city, and self-managed his 
medication by the use of a weekly pillbox. In January 2013, he was newly prescribed basal 
insulin by the general physician (GP) in addition to rapid-acting insulin that had been 
initiated years before. Amputation of digits I and II on the left foot had occurred after 
emergency hospitalisation in October 2010. He had no allergies and was a current smoker 
(30 pack years). At discharge, the patient was prescribed ten different medications 
representing 15 pills in a 4-times daily regimen (Table 1). Medication reconciliation, i.e. the 
comparison of pharmacotherapy before and after hospitalisation, showed that three 
medications were newly introduced, one dosing frequency was reduced, one strength was 
augmented, and intake times changed from 2-times daily to 4-times daily. 
 
INVESTIGATIONS 
Adherence to polypharmacy was measured by POlypharmacy Electronic Monitoring System 
(POEMS) affixed on a disposable weekly multidrug frame card with 28 unit-of-use doses 
spread over 7x4 plastic cavities, filled by the community pharmacist with all oral solid 
medication. 
 
TREATMENT  
During hospitalisation, a clinical pharmacist recommended to refer the patient to a 
pharmaceutical care service consisting of individualized counselling (knowledge of 
medication), packaging of solid oral medication into multidrug punch cards (facilitation of 
polypharmacy management), and electronic adherence monitoring (measurement-guided 
medication management). Insulin management did not require further instruction. The 
responsible physician approved the recommendation and the patient provided written 
informed consent. 
Two days prior to discharge, the pharmacist counselled the patient on indication, long-term 
benefit, adverse effects, and correct use of all discharge medication using standardized 
information sheets. The sheets were handed out instead of official package inserts upon the 
patient’s request. The pharmacist instructed the use of the multidrug punch card and tested 
the patient’s dexterity to remove tablets.  
At discharge, the patient was provided with one multidrug punch card equipped with POEMS, 
containing all prescribed oral solid medication for one week and his medication plan (Table 
1, Figure 1). 
 
Table 1: Medication plan handed out to the patient at hospital discharge.  
HTC, hydrochlorothiazide; n.p., no picture available.  
Medication plan for [patient name] *[year of birth] 
    
 
 
Physician       Date dd.mm.yyyy   
Ward       Visum     
Hotline: xxx xxx xx xx 
Medication   Dosage     Picture Indication Note 
Name   Dose morning noon evening night       
Irbesartan / htc 300/12.5 mg 1       
 
Blood pressure   
Aspirine® 100mg 1       
 
Blood thinning Before meal 
Atorvastatin 40mg     1   
 
Blood fat   
Pantoprazol 40mg 1       
 
Gastric acid   
Bisoprolol 2.5mg 1   1   n.p.  Blood pressure   
Clopidogrel 75mg 1       
 
Blood thinning   
Metformin 1000mg 1   1     Sugar   
Clindamycin 300mg 2 2   2 
 
Infection Stop on 07.05.13 
                  
Insulin Lisprum           n.p.  Sugar According to scheme 
Insulin Glargine           n.p.  Sugar According to scheme 
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Five days after discharge, the patient was called to consolidate the safe and correct 
management of the electronic multidrug punch card. Exchange of empty multidrug punch 
cards for new filled ones occurred every 2-4 weeks at a predefined community pharmacy. 
The electronic records of the previous week were discussed following a protocol for 
measurement-guided medication management (MGMM) [17] and using elements of 
motivational interviewing [24] like open-ended questions, reflective listening, affirmative 
style, enhancement of personal motivation, setting goals and obtainment of a change of 
plan.  
 
OUTCOME AND FOLLOW-UP   
The monitoring period lasted from February 18th 2013 (discharge day) until February 23rd 
2014 and covered 371 days. In total, 54 multidrug punch cards with 899 unit-of-use doses 
were handed out. All returned multidrug punch cards were empty (taking adherence by pill 
count of 100%). Eleven multidrug punch cards (20.4%) and 9 random days were not 
readable (technical failure), and 17 event times were not recorded, leading to lost data for 
218 doses (24.2%). The patient removed 8 pocket doses in anticipation of intakes away 
from home, which were excluded from the calculation. The summary of adherence statistics 
was derived from 673 electronic records. 
The first 79 days of treatment comprised 4-times daily intakes (QID) due to antibiotic 
treatment until 7th May 2013, and covered 21.3% of the observation period. On May 8th 
2013, the GP augmented bisoprolol from 2.5mg to 5mg twice daily without influence on the 
number of pills or the intake times. The next 292 days comprised twice-daily intakes (BID). 
A total of 278 doses were retrieved in the morning (QID: 63, BID: 215) in average at 7h 
34min ± 55min (QID: 7h 24min ± 27min, BID: 7h 36min ± 1h 1min). The antibiotics 
assigned to be taken at noon (63 doses) and at night (65 doses) were taken in average at 
12h 22min ± 2h 6min and at 21h 44min ± 44min, respectively. A total of 267 doses were 
retrieved in the evening (QID: 57, BID: 210) in average at 17h 39min ± 1h 1min (QID: 17h 
45min ± 8min, BID: 17h 37min ± 1h 14min). The electronic records over the whole year are 
displayed in Figure 2. 
A dosing interval was defined as correct if the time between doses was within 25% of the 
prescribed dosing interval, i.e., ± 3h for a 12-hour period (BID) and ± 1.5h for a 6-hour 
period (QID). Overall 96.9% of the dosing intervals were correct. All morning and evening 
doses of the QID regimen were taken in the grace period of 1.5 hrs, while 10/63 doses at 
noon and 4/65 doses at night were taken earlier or later, representing 5.4% of all QID 
doses. Of the BID regimen, 2/215 doses in the morning and 5/210 doses in the evening 
were taken outside the grace period of 3 hrs, representing 1.6% of all BID doses. 
The patient kept all 17 planed appointments for multidrug punch card exchange and 
feedback sessions. He went on vacations thrice for several weeks. During the 9 feedback 
sessions conducted regularly every 1-2 months, the patient confirmed the safe and correct 
use of the punch card. He was very satisfied with his electronic records and emphasized his 
efforts for a highly regular taking and timing adherence. He reported a strong integration of 
the process of medication taking into his daily routine, i.e. coupled to mealtimes and insulin 
injection. 
The patient was satisfied with the intervention and declared a feeling of increased 
medication safety owing to the multidrug punch card use. The electronic records used during 
the feedback sessions helped the patient to gain confidence in medication management and 
to maintain perfect regularity of the intakes. The electronic monitoring did not bother him. 
At the beginning, the removal of the medication out of the multidrug punch card caused him 
trouble because the back layer was hard to push through. However, he got used to it 
quickly, reported no more problems and wished to keep the punch cards after end of 
monitoring. 
During the 12 months of monitoring, the patient had no readmission to hospital and no 
emergency visit. Laboratory values remained stable (LDL: 2.9 mmol/l, 29.01.2014; TG: 2.2 
mmol/l, 29.01.2014; blood pressure: 193/88, 31.01.2014). HbA1C decreased to 7% 
(31.01.2014). 
 
DISCUSSION  
Page 3 of 9
 
We found 3 close case reports in literature. First, a 79-year old Japanese female with type 2 
diabetes and mild cognitive impairment took all medication 3-times daily from a sounding 
and light flashing electronic device.[25] After 6 months, adherence by pill count was one 
missed dose per week (95%) and HbA1C decreased from 8.0 to 7.1%, demonstrating the 
efficacy of the electronic reminder device. Second, a 17-year old female treated for Fanconi 
Anaemia with 8 drugs daily had an estimated adherence of 25%.[26] She received 35 
motivational interviewing sessions over 17 months. Adherence to the lead medication 
levothyroxine measured by electronic pill bottle showed a significant improvement up to 
82%, demonstrating the efficacy of motivational interviewing. Third, a 65-year old Swiss 
male with epilepsy and suspected abuse of sleeping pills was monitored with electronic 
multidrug punch cards over 3 weeks.[27] Inadequate medication intake behaviour could be 
corrected with feedback sessions. 
Our case with pharmaceutical care service including electronic monitoring of adherence to 
polypharmacy and regular feedback on electronic records was successful to maintain perfect 
adherence and clinical stability during one year. A glycosylated haemoglobin (HbA1C) level of 
7% was reached during the one-year monitoring period and represents the target level 
recommended by the American Diabetes Association (ADA) and the European Association for 
the Study of Diabetes (EASD) for elderly comorbid patients.[28] The lowering of the HbA1C 
by 1% is known to improve micro- and macrovascular clinical endpoints significantly and to 
reduce all-cause mortality by 14%.[29] In our case, the HbA1C reduction probably followed 
from the adjustment of insulin therapy one month before hospitalisation. However, the 
impact of multidrug punch cards was demonstrated by a mean HbA1C reduction of 0.95% in 
36 diabetic patients with oral antidiabetics after 8 months in a randomized controlled 
trial.[30] We thus can suppose that for our patient, the multidrug punch card acted as a 
railing and interrelated the oral therapy with the insulin therapy. 
The challenging therapy plan of 4-times daily intake for over a fifth of the observation time 
and changes in daily routine like vacation had no influence on the patient’s adherence. 
Because frequent dose dispensing and interruption in daily life were reported to negatively 
affect adherence [31-33] we assume that the multidrug punch card (as practical tool) 
coupled to the continuous feedback sessions (as external motivator) were able to 
consolidate and maintain perfect adherence. This assumption is supported by a meta-
analysis attributing a large effect to the intervention of feedback on electronic dosing 
history.[34]  
We acknowledge some limitations. The substantial loss of data due to technical flaws of our 
first generation POEMS is inherent in newly developed technologies. The subsequent 
generation of electronic foils will be improved. Electronic monitoring is often criticized to 
assume rather than prove the patient’s actual medication intake. However, we observed that 
patients usually accept monitoring and thus swallow the removed medication.[35] Finally, 
the patient’s being aware of observation is supposed to have an impact on the outcomes. 
However, a recent study showed that the use of an electronic device leads to a small, non-
significant increase in adherence compared to standard packaging.[36] In conclusion, this 
case is to our knowledge the first report of long-term monitoring of polypharmacy associated 
with the benefit of successful disease management. 
 
LEARNING POINTS/TAKE HOME MESSAGES 3 to 5 bullet points 
• The pharmaceutical care intervention - comprising electronic monitoring of adherence 
to polypharmacy and recurrent feedback sessions – maintained optimal adherence 
and stabilized disease management. 
• The patient accepted the electronic monitoring of adherence to polypharmacy over 
one year and was satisfied with the service. He was even willing to continue with this 
service after study end. 
• Electronic monitoring of polypharmacy was feasible over one year and yielded 
valuable results. 
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FIGURE/VIDEO CAPTIONS  
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Figure 1. Electronic multidrug punch card front (left) and back with affixed POlymedication 
Electronic Monitoring System (POEMS; right). 
 
Figure 2. Electronic records over the one-year monitoring period. 
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